raloxifene hydrochloride has been researched along with Reperfusion Injury in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Concors, SJ; Ge, G; Hancock, WW; Hernandez, P; Levine, MH; O'Brien, C; Wang, Z | 1 |
Ali, RAH; Altimimi, M; Hadi, NR | 1 |
Asakura, M; Asanuma, H; Hori, M; Kitakaze, M; Liao, Y; Mori, H; Node, K; Ogita, H; Sanada, S; Shinozaki, Y; Takashima, S | 1 |
3 other study(ies) available for raloxifene hydrochloride and Reperfusion Injury
Article | Year |
---|---|
The Selective Estrogen Receptor Modulator, Raloxifene, Is Protective Against Renal Ischemia-reperfusion Injury.
Topics: Acute Kidney Injury; Animals; Creatinine; Dimethyl Sulfoxide; Estrogens; Female; Fibrosis; Kidney; Mice; Mice, Inbred C57BL; Raloxifene Hydrochloride; Reperfusion Injury; Selective Estrogen Receptor Modulators | 2022 |
The potential renoprotective effect of Raloxifene in renal ischemia-reperfusion injury in a male rat model.
Topics: Animals; Antioxidants; Caspase 3; Creatinine; Ischemia; Kidney; Kidney Diseases; Male; Oxidative Stress; Raloxifene Hydrochloride; Rats; Reactive Oxygen Species; Reperfusion Injury; Tumor Necrosis Factor-alpha; Urea | 2023 |
Amelioration of ischemia- and reperfusion-induced myocardial injury by the selective estrogen receptor modulator, raloxifene, in the canine heart.
Topics: Animals; Charybdotoxin; Dogs; Enzyme Inhibitors; Mitogen-Activated Protein Kinase Kinases; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Peroxidase; Potassium Channels, Calcium-Activated; Raloxifene Hydrochloride; Reperfusion Injury; Selective Estrogen Receptor Modulators | 2002 |